About Mallax Pharma
Sustainability, medical need, and profitable growth are cornerstones of Mallax’s strategy, and they will define how we operate and build our company. Our aim is to build a new leading pharma and healthcare company in Europe.
In 2021, Mallax acquired Sana Pharma Medical AS, a Nordic pharma company headquartered in Oslo. Mallax is the holding company, and all operational activities are carried out through Sana Pharma Medical.
1 July 2021 Mallax acquires Sana Pharma Medical and creates a new Nordic pharmaceutical platform. Download full press release.
20 December 2020 Impilo and Anders Larnholt form a partnership to create a new pan- European pharmaceutical platform. Download full press release.